Patents by Inventor Michael B. Maurin

Michael B. Maurin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF REDUCING THE BODY WEIGHT OF A SUBJECT BY ADMINISTERING A FATTY ACID ESTER OF AN ESTROGEN OR ESTROGEN DERIVATIVE IN AN OIL AND COMPOSITIONS CONTAINING THE SAME
    Publication number: 20080261936
    Abstract: Compositions and methods for reducing the body weight of a subject are disclosed. The invention is directed to methods for reducing the body weight in a subject comprising administering therapeutically effective amounts of a fatty acid ester of an estrogen or estrogen derivative in an oil. Furthermore the invention is directed to compositions for reducing the body weight in a subject comprising administering therapeutically effective amounts of a fatty acid ester of an estrogen or estrogen derivative in an oil.
    Type: Application
    Filed: September 6, 2007
    Publication date: October 23, 2008
    Inventors: Michael B. Maurin, Nutan K. Gangrade, Kristi O. Lenz, Bindu Tejura
  • Crystalline Efavirenz
    Patent number: 6673372
    Abstract: The potent reverse transcriptase inhibitor Efavirenz is produced in crystalline form. Crystalline Efavirenz exists in several physical forms which are-designated Forms 1, 2, 3 and 4, and are characterized by x-ray powder diffraction and differential scanning calorimetry. Pharmaceutical compositions and methods are useful for the treatment of the human immunodeficiency virus (HIV).
    Type: Grant
    Filed: June 10, 1999
    Date of Patent: January 6, 2004
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Lilian A. Radesca, Michael B. Maurin, Shelley R. Rabel, James R. Moore
  • Oral liquid formulations of benzoxazinones HIV reverse transcriptase inhibitors
    Publication number: 20020061884
    Abstract: A palatable oral liquid pharmaceutical composition of benzoxazinone compounds useful as HIV reverse transcriptase inhibitors comprising the benzoxazinone active ingredient in a liquid vehicle comprising a vegetable oil selected from olive oil, peanut oil, soybean oil, corn oil, safflower oil, sunflower oil, canola oil or walnut oil. Other formulating agents such as sweetening agents, lecithin suspending agents, etc. may be optionally added.
    Type: Application
    Filed: November 12, 2001
    Publication date: May 23, 2002
    Inventors: Surendra M. Bahal, Michael B. Maurin
  • Oral liquid formulations of benzoxazinones HIV reverse transcriptase inhibitors
    Patent number: 6235733
    Abstract: A palatable oral liquid pharmaceutical composition of benzoxazinone compounds useful as HIV reverse transcriptase inhibitors comprising the benzoxazinone active ingredient in a liquid vehicle comprising medium chain fatty acid triglycerides. Other formulating agents such as sweetening agents, lecithin suspending agents, etc. may be optionally added.
    Type: Grant
    Filed: February 16, 1999
    Date of Patent: May 22, 2001
    Assignee: DuPont Pharmaceuticals Company
    Inventors: Surendra M. Bahal, Michael B. Maurin
  • Etanidazole injectable solution
    Patent number: 5192784
    Abstract: Physically and chemically stable pharmaceutical compositions useful for administering etanidazole by injection are described. These compositions are essentially aqueous solutions having a pH less than or equal to 5.5, and containing etanidazole, a buffer system, and a tonicity-adjusting agent, and they are optionally stabilized by the addition of a stabilizing agent or by autoclaving.
    Type: Grant
    Filed: June 26, 1992
    Date of Patent: March 9, 1993
    Assignee: Du Pont Merck Pharmaceutical Company
    Inventors: Surendra M. Bahal, Kenneth S. Field, Michael B. Maurin